
Join to view full profile
655 Fox Run RdSte CFindlay, OH 45840
Phone+1 567-525-3163
Fax+1 567-525-3169
Dr. Iboaya is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Benahili Iboaya, DO, is a nephrologist based in Findlay, OH, specializing in areas such as hypertension, chronic kidney disease, and end-stage renal disease. He completed his residency in Internal Medicine from 2003 to 2006 at the University of Missouri-Kansas City School of Medicine, followed by a Nephrology fellowship from 2006 to 2008 at the University of Mississippi Medical Center. He is an alumnus of the Oklahoma State University Center for Health Sciences, Class of 2003. His research has been published in the journal "Renal Failure," with notable work on resolving recalcitrant hypoglycemia. Dr. Iboaya has been recognized with the Sigma Sigma Phi Academic Honor Society award in 2000 and received the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2012.
Education & Training
University of Mississippi Medical CenterFellowship, Nephrology, 2006 - 2008
University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 2003 - 2006
Oklahoma State University Center for Health SciencesClass of 2003
Certifications & Licensure
AZ State License 2024 - 2026
OH State License 2008 - 2026
IN State License 2024 - 2025
KY State License 2024 - 2025
NV State License 2025 - 2025
TN State License 2024 - 2025
MO State License Active through 2013
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification AltaPoint EHR, AltaPoint Data Systems, 2012
- Sigma Sigma Phi Academic Honor Society 2000
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- Recalcitrant hypoglycemia resolved with 2.5% dextrose containing replacement fluid during hemodiafiltrationTibor Fülöp, Benahili U. Iboaya, Ramachandram Avusula, Éva Csongrádi, Luis A. Juncos
Renal Failure. 2013-07-16
Journal Articles
- Recalcitrant hypoglycemia resolves with 2.5% hemodiafiltratiin fluidTibor Fulop, Benahili U Iboaya, Ramachandram Avusula, Renal Failure, 7/5/2013
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: